Gemcitabine Plus Cisplatin Versus Gemcitabine Chemotherapy for Advanced Biliary Tract Cancer
Annals of Oncology. 2013;24:iv70 
Gemcitabine Plus Cisplatin Versus Capcitbine Plus Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancer
Annals of Oncology. 2014;25:iv245
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Yearbook of Surgery. 2011;2011:310-312
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Yearbook of Gastroenterology. 2010;2010:96-97
Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review
Cancer Research and Treatment. 2015;47(3):343-361
Cost-Effectiveness of Gemcitabine Plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan
Value in Health. 2013;16(7):A416
Cost-utility analysis of triplet therapy using gemcitabine, cisplatin, and S-1 for the primary treatment of advanced biliary tract cancer.
. 2022;
Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer
Asia-Pacific Journal of Clinical Oncology. 2016;13(1):13-20
Gemcitabine and cisplatin plus immunotherapy in advanced biliary tract cancer: a phase II study
Nature Reviews Gastroenterology & Hepatology. 2022;19(5):280-280
Advanced Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin (GEMCIS) and Novel Inflammatory Markers
Journal of Gastrointestinal Cancer. 2020;52(1):294-299